Checkpoint Therapeutics (NASDAQ:CKPT) Price Target Cut to $69.00

Checkpoint Therapeutics (NASDAQ:CKPT – Get Rating) had its target price reduced by LADENBURG THALM/SH SH from $96.00 to $69.00 in a research note released on Monday morning, The Fly reports. They currently have a buy rating on the stock. A number of other research analysts also recently issued reports on CKPT. Lake Street Capital reduced […]

Related Keywords

,Armistice Capital ,Renaissance Technologies ,Morgan Jesss Co ,Asset Group Inc ,Asset Management Corp ,Checkpoint Therapeutics Company Profile ,Checkpoint Therapeutics Inc ,Checkpoint Therapeutics ,Get Rating ,Street Capital ,Therapeutics Stock Down ,Asset Group ,Management Corp ,Checkpoint Therapeutics Daily ,Nasdaq Ckpt ,Ckpt ,Medical ,Lower Price Target ,Ladenburg Thalm Sh ,